KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $44.0 million.

  • CareDx's Accumulated Expenses fell 292.81% to $44.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.0 million, marking a year-over-year decrease of 292.81%. This contributed to the annual value of $43.4 million for FY2024, which is 471.46% down from last year.
  • According to the latest figures from Q3 2025, CareDx's Accumulated Expenses is $44.0 million, which was down 292.81% from $44.0 million recorded in Q2 2025.
  • CareDx's Accumulated Expenses' 5-year high stood at $50.2 million during Q2 2023, with a 5-year trough of $23.6 million in Q1 2021.
  • For the 5-year period, CareDx's Accumulated Expenses averaged around $42.5 million, with its median value being $45.3 million (2024).
  • In the last 5 years, CareDx's Accumulated Expenses surged by 8993.57% in 2022 and then plummeted by 739.66% in 2023.
  • Over the past 5 years, CareDx's Accumulated Expenses (Quarter) stood at $37.9 million in 2021, then grew by 29.56% to $49.1 million in 2022, then decreased by 7.4% to $45.5 million in 2023, then decreased by 4.71% to $43.4 million in 2024, then rose by 1.4% to $44.0 million in 2025.
  • Its Accumulated Expenses stands at $44.0 million for Q3 2025, versus $44.0 million for Q2 2025 and $42.9 million for Q1 2025.